InvestorBrandNetwork (IBN) Content Platform

The Long Cramer Tracker ETF (CBOE: LJIM) will be closed and liquidated. The decision was made by the Board of Trustees of the Northern Lights Fund Trust IV, which authorized an orderly liquidation of the fund. According to the announcement, board members determined that “closing and liquidating the fund was in the best interests of the fund and its shareholders.” The announcement noted that the last day for trading of LJIM shares will be Sept. 11, 2023; that will also be the last day the fund will accept creation units from authorized participants. “We started LJIM in order to facilitate a conversation with Jim Cramer around his stock picks as the other side to the Short Cramer ETF (SJIM),” said Long Cramer Tracker ETF fund adviser Matthew Tuttle in the press release. “Unfortunately, Mr. Cramer and CNBC have been unwilling to engage in dialogue and instead have chosen to ignore the funds; therefore, there is no reason to keep the long side going. Going forward we will just focus on the short side.”

To view the full press release, visit https://ibn.fm/PCDNk

About the Long Cramer Tracker ETF

The Long Cramer Tracker ETF seeks to provide investments results that generally track, before fees and expenses, the results of the investments recommended by television personality Jim Cramer. For more information, please visit www.CramerETFs.com/ljim.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

RJD Green (OTC: RJDG) today announced that its software division, IOSoft Systems, procured a custom software development and IT support contract with the RailPro Group, a consulting and marketing team focused on energy-related companies and retail marketing, for customization of the IOSoft platform, ioSoft Suites. According to the announcement, the agreement will incorporate usage of the ioSoft LinkUP(C) communication software and the ioSoft Suites adjudication and accelerated payment systems. ioSoft Suites now includes claims processing, adjudication and multi-level communications and accurate data collection software systems. IOSoft offers integrated system pricing and claims payment to enhance productivity, efficiency and costs. The software solutions can be utilized individually or as a total claims and payment management system. ioSoft LinkUP is the ultimate communication interface, enabling plan participants to access their ID cards, update enrollment and access claim information 24/7 via iPhone or Android. With 24/7 access through their tablet or laptop, plan administrators are able to review and approve enrollment or access the system database as needed.

To view the full press release, visit https://ibn.fm/zXXij

About RJD Green Inc.

RJD Green operates as a holding company focused on acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSoft Inc., a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies and Silex Holdings Division, which is focused in specialty construction and industrial services. The initial operations, Silex Interiors, fills a market niche between big box stores like Home Depot and local contractors. Silex manufactures and installs granite and other countertops, cabinets and related products for residential builders, commercial contractors, remodeling contractors and DIY customers. For more information about the company, visit www.RJDGreen.com.

NOTE TO INVESTORS: The latest news and updates relating to RJDG are available in the company’s newsroom at https://ibn.fm/RJDG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Long Cramer Tracker ETF (CBOE: LJIM) will be closed and liquidated. The decision was made by the Board of Trustees of the Northern Lights Fund Trust IV, which authorized an orderly liquidation of the fund. According to the announcement, board members determined that “closing and liquidating the fund was in the best interests of the fund and its shareholders.” The announcement noted that the last day for trading of LJIM shares will be Sept. 11, 2023; that will also be the last day the fund will accept creation units from authorized participants. “We started LJIM in order to facilitate a conversation with Jim Cramer around his stock picks as the other side to the Short Cramer ETF (SJIM),” said Long Cramer Tracker ETF fund adviser Matthew Tuttle in the press release. “Unfortunately, Mr. Cramer and CNBC have been unwilling to engage in dialogue and instead have chosen to ignore the funds; therefore, there is no reason to keep the long side going. Going forward we will just focus on the short side.”

To view the full press release, visit https://ibn.fm/PCDNk

About the Long Cramer Tracker ETF

The Long Cramer Tracker ETF seeks to provide investments results that generally track, before fees and expenses, the results of the investments recommended by television personality Jim Cramer. For more information, please visit www.CramerETFs.com/ljim.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries, today released financial results for the second quarter ended June 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of 2023. Among the highlights, the company reported total revenue of $511,800 for the second quarter of 2023 and $1,252,403 for the first half of 2023, reflecting increases of 3% and 28%, respectively, from the same periods last year.

“We were pleased to report all-time record revenue in first half 2023, despite our focus on preparations for the commercial launch and scale up of our UltraShear technology platform in late May,” said Richard T. Schumacher, president and CEO of PBIO. “We more recently announced the initial surge in UltraShear distributor sign-ups and orders, which we believe will continue at an increasing rate through the coming months. We anticipate strong UltraShear revenues in 2nd Half 2023 and the announcement of contracts with multiple name brands across a diversity of industries.”

To view the full press release, visit https://ibn.fm/gLVfV

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its products utilize both constant and alternating pressure. The company’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

GolfLync, the leading social networking platform for golfers, is making waves in the golfing community with its rapid growth and exceptional user engagement. With more than 55,000 downloads and a thriving user base, GolfLync is transforming the way golfers connect, engage and build vibrant communities. Among GolfLync’s standout features is Virtual Golf Clubs(TM) (“VGC”), with over 500 communities already formed on the platform. These VGCs provide a space for like-minded golfers to share their passion for the game, organize outings and connect with fellow enthusiasts. “We are thrilled to see the tremendous growth and engagement within the GolfLync community,” said Noah DiPasquale, co-founder and CEO at GolfLync. “We remain committed to enhancing the user experience and continuing to provide a platform that truly enriches the golfing community. We are very excited at our rapid growth, user engagement and the feedback we’ve received from the industry.”

To view the full press release, visit https://ibn.fm/SMdLa

About GolfLync Inc.

GolfLync is a leading social networking platform designed exclusively for golfers. With a focus on community building and user engagement, GolfLync connects golf enthusiasts, fosters vibrant virtual golf clubs, and enhances the overall golfing experience. GolfLync is available for download on the Apple App Store and the Google Play Store. For more information about GolfLync, visit www.GolfLync.com, download the app, and connect with community on Facebook, X and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TRxADE Health (NASDAQ: MEDS), a pharmaceutical exchange platform provider that recently merged with food technology and distribution company Superlatus Inc., announced an acquisition agreement. The company has entered a binding agreement with Perfect Day Inc. to acquire the Urgent Company Inc. along with its Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. consumer brands. According to the announcement, the combined company will have a sustained, equitable food portfolio designed to penetrate new markets and accelerate a transition to animal-free brands more readily. Superlatus is a diversified food-technology company with distribution capabilities that is working to scale food innovation and transformational change designed to optimize food security and population health via innovative CPG products, agritech, foodtech, plant-based proteins and alt-proteins.

A new type of CPG company, the Urgent Company is focused on the next generation of consumer brands that leverage the latest in innovation and science to create revolutionary, delicious and sustainable animal-free foods that create less impact on the planet. “We are excited to welcome the Coolhaus, Brave Robot, Modern Kitchen and California Performance Co. brands to our portfolio of CPG assets,” said Superlatus interim CEO Tim Alford in the press release. “Together, our shared interest in the sustainable and equitable food sectors will, we believe, allow us to expand our market presence and pursue a number of new opportunities to grow our brands together. In addition, once complete, this acquisition will help accelerate both companies’ environmental mission to transition our products to animal free in the months and years ahead.”

To view the full press release, visit https://ibn.fm/QpNW3

About TRxADE Health Inc.

TRxADE is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving more than 14,500 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit www.TRxADE.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced its appointment of Cindy Anderson as chief financial officer (“CFO”), effective Aug. 21, 2023. Anderson succeeds Jerrold Dotson, whose planned retirement was announced in July of this year. “We are delighted to welcome Ms. Anderson, an experienced and highly accomplished finance professional, to our team,” said Vistagen CEO Shawn Singh. “As CFO, Ms. Anderson will leverage deep experience in corporate strategic and financial operations while managing finance and growth objectives as we work to bring novel CNS treatments to patients. On behalf of Vistagen, I’d like to express our sincere gratitude to Mr. Dotson for his dedicated service and invaluable contributions to the company during his remarkable tenure. As he embarks on his retirement, we extend our best wishes for success and fulfillment in the future. At the same time, we remain steadfast in our work to advance our mission and enthusiastically welcome Ms. Anderson to our accomplished team.”

To view the full press release, visit https://ibn.fm/7LlDo

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. Vistagen is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those currently available for the treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), “PH15,” “PH80,” and “PH284,” each an investigational agent belonging to a new class of drugs known as pherines, as well as “AV-101,” which is an oral prodrug of an antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines are neuroactive nasal sprays designed with an innovative proposed mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic absorption or direct activity on neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced that Darren Heitner, Esq. has signed on as a brand ambassador for Safety Shot, the world’s first blood alcohol detox drink to launch Q4 2023. The founder of Heitner Legal, P.L.L.C., Heitner is an adjunct professor of sports law at the University of Florida Levin College of Law, an adjunct professor of NIL (name, image, likeness) at the University of Miami School of Law, a certified arbitrator with the American Arbitration Association, and author of many books published by the American Bar Association. “Darren is a leading advocate for athletes, and he is an innovator in his own right as an attorney who has pioneered NIL, helping to bring brands and athlete-influencers together,” said Jupiter Wellness CEO Brian John. “We are pleased that he has come on board to raise awareness around Safety Shot and its wellness benefits for athletes, sports fans and everyone else who likes to enjoy a drink safely and with little if any recovery time.”

To view the full press release, visit https://ibn.fm/UODg1

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products and licensing royalties. The company recently acquired Safety Shot, the world’s first blood alcohol detox drink. Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for email alerts at JupiterWellness.com/email-alerts and by following Jupiter Wellness on Twitter and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that develops new generation power-control electronics that expand the capabilities of electric motors and batteries, today announced another milestone achievement with certification of its Cell Driver(TM) battery modules to the Underwriters Laboratories’ (“UL”) 1973 standard. “We are thrilled to progress our Cell Driver to near the finish line of UL certification,” said Exro CEO Sue Ozdemir. “To mitigate the effects of climate change, energy storage is an important component in the ecosystem required for a sustainable electrified future. Through our expertise in power electronics, Exro delivers real-world solutions that change how the world consumes energy. Our patented technology will provide commercial and industrial applications with high-quality, safe and reliable energy while alleviating stress on existing grid infrastructure.”

To view the full press release, visit https://ibn.fm/HGpwL

About Exro Technologies Inc.

Exro Technologies is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM)), and act to accelerate adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has closed on its a purchase agreement with Rio Tinto Exploration Canada Inc., a subsidiary of Rio Tinto Inc. The agreement outlines the C$1.5 million acquisition of a portfolio of exploration-stage projects in the Athabasca Basin in Saskatchewan. According to the announcement, UEC has acquired a 60% equity stake in the Henday Lake joint venture, 100% of the Milliken project and a 50% equity stake in the Carswell joint venture project. The company noted that, with the completion of this transaction, it has added an additional 44,444 acres of prospective ground in the Athabasca Basin to its existing portfolio of 1,091,639 acres. The Henday project is 17,801 acres north of Roughrider and lies within the prolific Wollaston-Mudjatik transition zone that is host to many of the eastern Athabasca deposits.

The Carswell project is 16,771 acres just north of the now mined out Claude Deposit at Cluff Lake. Milliken is 9,872 acres located along the strike of the company’s Wolf Lake trend on its Hidden Bay project. “This is our third acquisition in the Athabasca Basin in the last 12 months and builds on the landmark acquisitions of UEX and the Roughrider project,” said Uranium Energy CEO and president Air Adnani in the press release. “This acquisition represents an important component in our strategy to assemble a premier North American uranium portfolio, featuring near-term U.S. production, Canadian development-stage projects including joint ventures, and a pipeline of exploration projects with excellent growth potential. Since the acquisitions of Roughrider and UEX last year, the Canadian team has issued technical reports on the Roughrider, Horseshoe-Raven and the Shea Creek deposits. We have also added James Hatley as vice president production, Canada to the team to augment the advancement of our Canadian assets towards production.”

To view the full press release, visit https://ibn.fm/dp1tj

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly, in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in south Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group (NASDAQ: TIO), a profitable and fast-growing fintech and agrifintech company, has postponed its Q22023 earnings release and conference call again; the company has also rescheduled the filing of its Form 10-Q for the period ended June 30, 2023. The company notes that progress has been made with the independent review of the allegations made in the Hindenburg short-seller report, the independent review is not yet completed. Therefore, the company and its independent auditors need additional time to complete the Form 10-Q and financial statements.

To view the full press release, visit https://ibn.fm/TxKUb

About Tingo Group Inc.

Tingo Group is a global fintech and agrifintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a value-added service platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and has entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that is currently in beta version and offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cybin (NYSE American: CYBN) (NEO: CYBN) was featured in a recent interview with Proactive Investors that covers protection of the company’s IP with the granting of a second U.S. patent for its its deuterated analog programs. Cybin CEO Doug Drysdale joined Steve Darling from Proactive to share news of the patent granted by the U.S. Patent and Trademark Office. The patent “is expected to provide exclusivity until 2041 and encompasses composition of matter claims for deuterated tryptamines. These claims support various programs within Cybin, including CYB003, a deuterated psilocybin analog, and CYB004, a deuterated dimethyltryptamine. The patent also covers methods of treating major depressive disorder and treatment-resistant depression,” reads the update. During the interview, Drysdale explained that CYB003 is a proprietary deuterated psilocybin analog developed for the potential treatment of major depressive disorder. The deuterated structure of CYB003 aims to optimize its therapeutic profile, which includes rapid onset of effect, shorter treatment duration and efficacy at lower doses. CYB003 is currently undergoing phase 2 clinical trials involving participants with moderate to severe MDD. In addition, Drysdale mentioned CYB004, an investigational deuterated dimethyltryptamine program targeted for the potential treatment of generalized anxiety disorder.

For more information, visit https://ibn.fm/OZH6x

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental health care is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, is increasing its reach in Chicago as well as in Mississippi and Georgia through new or expanded distribution agreements. The company announced that it has inked agreements with Chicago’s Lakeshore Beverage, Mississippi’s Southern Beverage Company and Georgia’s United Distributors. In addition, SBEV announced that its Copa di Vino offering can now be found in nine Blaze Pizza locations in Southern California. According to the announcement, SBEV’s agreement with Lakeshore Beverage calls for the company to provide Pulpoloco in 7-Eleven stores throughout Chicago. The Mississippi distribution agreement is with Southern Beverage Company, a family-owned business since 1939 that has five distribution centers and more than 260 employees and that distributes products to 2,100 locations across 32 counties. Georgia-based United Distributors is the largest beverage alcohol distributor in both Georgia and Alabama.

“We’re proud to announce all these agreements at the same time,” said Splash Beverage CEO Robert Nistico in the press release. “We’ve been hard at work over the past few months putting all these pieces into place, and as can be seen, Splash’s footprint has increased significantly with this announcement. This is exciting news as we continue to execute on our distribution and retail strategy. As I discussed a couple of months ago, we push for distribution, support those efforts with marketing, then start pushing again for more distribution coverage. We’re getting additional coverage through Southern California, the mountain states, Chicago, Mississippi, and Georgia. We’re humbled to partner with all the great names in these regions and look forward to raising our visibility across the retail distribution world.”

To view the full press release, visit https://ibn.fm/zx2fq

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and nonalcoholic beverage brands including Copa di Vino wines by the glass, SALT flavored tequilas, Pulpoloco sangrias, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, has successfully exposed a part of the main Augustus Prospect lithium pegmatite system through stripping and channel sampling. The company made the announcement, noting that Outcrop #26 was discovered on the east side of the main Augustus Prospect area where a lithium rich pegmatite cuts 14.7 meters at 1.15% lithium oxide (“Li2O”). Other highlights of the assay include Outcrop #900 near the North American Lithium (“NAL”) mine, which cuts 10 meters at 0.52% Li2O; four grab samples collected from the Lac Fiedmont area returned low lithium values; six grab samples collected from Duval Lithium Prospect returned high lithium values in the range of 0.004% to 2.15% Li2O with average 1.14% Li2O; and 19 grab samples from Bella Prospect near the NAL mine returned lithium values in the range of 0.005% to 1.26% Li2O with anomalous values of other rare metals. The company anticipates further exploring both the Duval Lithium and Bella Prospects. “To date the company has drilled 68 drill holes with over 15,000 meters of NQ-size diamond drilling on the property and has intercepted multiple lithium pegmatite dykes of variable lengths, widths and lateral continuity,” the announcement stated. “The company has further explored the newly discovered lithium pegmatite zones in two areas to the southeast of the Augustus Prospect, which are located near the North American Lithium Mine.”

To view the full press release, visit https://ibn.fm/gSkiY

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. The company’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FEBatteryMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

MetAlert (OTC: MLRT), a pioneer in location-sensitive, health-monitoring devices and wearable technology products for remote patient monitoring, is reporting on its focus on and progress in the artificial intelligence (“AI”) healthcare space. According to the announcement, the company is initiating a series of RFPs and detailed discussions with potential developers and strategic partners. By doing so, the company is indicating its vision to “incorporate groundbreaking capabilities of artificial intelligence into its various technology platforms, marking this a critical pivot for the wearable healthcare sector, and commitment to fully harness the potential of artificial intelligence to help shape the future of healthcare.” The company noted that the industry is projected to reach $63 billion by 2025, and MetAlert is dedicated to doing more than simply enhancing its remote patient monitoring solutions; the company is focused on integrating AI into its products and marking a pathway that lays the foundation for predictive healthcare.

The announcement specifically referenced MetAlert’s suite of wearable technologies, including its patented GPS SmartSole(R) and the RoomMate 3D infrared fall detection system. These products are designed to capture data in real-time, and this data will soon interface with an AI system designed to provide key predictive analytics that can offer invaluable insight into health patterns as well as relevant alerts concerning potential health disturbances and a proactive effort to prevent major medical incidents. “Wearable technology devices are collecting data in real-time all over the world, and adding AI into our technological foundations isn’t merely an evolution — it’s a declaration of our vision, mission and goals to unleash our full value proposition,” said MetAlert CEO Patrick Bertagna in the press release. “Our trajectory isn’t just about keeping pace with wearable tech advancements; it’s about setting our sights on transforming healthcare, delivering a better quality and longevity of life, championing a vision for a healthier, interconnected world and maximizing value for our stakeholders.”

To view the full press release, visit https://ibn.fm/LNT3Z

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing and licensing products, services and intellectual property in the wearable technology, personal location, wandering assistive technology, and health-data collection and monitoring business. MetAlert’s versatile solutions meld effortlessly across a gamut of applications—from consumer-focused products to specialized platforms tailored for enterprise and governmental audiences. With years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technologies, enabling caregivers to track and monitor patients in real-time. Known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, MetAlert and its flagship product stands as the world’s premier invisible wearable monitoring solution, tailor-made for individuals vulnerable to wandering — a boon for caregivers of Alzheimer’s, dementia, autism and traumatic brain injury patients. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about this company, please visit www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company focused on delivering mobile live dealer technology to global online gaming operators, has been granted a license by the Alcohol and Gaming Commission of Ontario. “AGCO” is the regulatory agency responsible for the oversight of the modern open and regulated iGaming and sports betting market in Ontario. “Receiving our supplier license for Ontario is another major milestone for our company, and we are extremely excited for the opportunity in this market,” said Darcy Krogh, president and CEO of Playgon Games. “Not only is it our first entrance into North America for our mobile-first live dealer technology, we have significant interest for our product in this market that we will announce in due course. Ontario has quickly become among the top five iGaming jurisdictions in North America, and live dealer tables accounted for 32% of the revenue generated within the online casino vertical, which makes it a very attractive market for us to pursue.”

To view the full press release, visit https://ibn.fm/aNCx6

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, the company’s products are ideal turnkey solutions for online casinos, sportsbook and land-based operators, media groups, and big database companies. For further information, please visit the company’s website at www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group (NASDAQ: TIO), a profitable and fast-growing fintech and agrifintech company, announced that it will release its second-quarter 2023 financial and company results today after market close; the company plans to release the report at a conference call slated to begin at 5 p.m. ET. During the call, company officials will release the Q2 report as well as discuss those results and provide a business update. A press release detailing the results will be issued prior to the call. Those interested in participating in the conference call may dial toll-free 1-877-704-4453 or 1-201-389-0920 (internationally), then enter conference code 13739698. A replay of the call will be available through Sept. 21, 2023, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the same pin number.

To view the webcast, visit https://ibn.fm/Oz5xg

To view the full press release, visit https://ibn.fm/0AWTF

About Tingo Group Inc.

Tingo Group is a global fintech and agrifintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agrifintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a service-added platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that is currently in beta version and offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has announced a new member of its board of directors. The company appointed Michelle Makori to the position. An acclaimed broadcast journalist, news anchor, reporter and producer, Makori currently serves as editor-in-chief and lead anchor at Kitco News, a media platform focused on commodities and precious metals. Makori has worked for Bloomberg, CNN Money, i24News and SABC. As an anchor and reporter, she has gained impressive experience covering and analyzing global economic, financial, and geopolitical news for more than two decades. In those positions, she has interviewed heads of state, CEOs of Fortune 500 companies, and other political, business, and entertainment leaders. In addition to her new career, Makori often appears as emcee, host and panel moderator for conferences and events around the globe. “On behalf of our board of directors, we are very pleased to welcome Michelle as a new director,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “I look forward to working with Michelle; she brings a valuable expertise and market insights to McEwen Mining.”

To view the full press release, visit https://ibn.fm/jpJ96

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 52% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million; his annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• A report published by Allied Market Research noted that in 2019, the global challenger bank market generated $20.4 billion and should post over $471 billion in revenue by 2027
• This growth will be attributed to the reduced associated costs, accessibility and overall convenience that the challenger bank market offers
• Through its strategic acquisition approach, FEXD is advancing this sector while offering consumers the services and flexibility they need
• By doing so, FEXD hopes to reduce poverty, improve the lives of the unbanked, and offer security and saving options for migrant workers

Fintech Ecosystem Development (NASDAQ: FEXD) is, through strategic mergers and acquisitions, helping accelerate the growth of the challenger bank market. In turn, the company is making financial services affordable and accessible, particularly to individuals in emerging markets, who grossly lack this access compared to their counterparts in developed regions. This focus is helping FEXD carve out a significant market share and leave an indelible mark, even as the world gradually shifts to digital currency.

In a report published by Allied Market Research, it was noted that, in 2019, the global challenger bank market generated $20.4 billion. The report then estimated that, by 2027, this market would post over $471.0 billion in revenue, representing a CAGR of 48.1% over the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

The Sustainable Green Team (OTCQX: SGTM), a provider of environmentally conscious solutions in the arbor care, disposal and recycling industries, will be featured in an upcoming episode of FMW Media’s “New to the Street,” a nationally syndicated program. The company is one of five to be showcased on New to the Street’s 503rd broadcast, airing at 3:30 p.m. ET on Saturday, Aug. 18, 2023. The company’s Director of Administration Brian Rivera and CEO Brian Meier will join host Jane King to discuss SGTM’s environmentally conscious solutions, strong team and sustainable business practices of converting waste into usable organic products.

To view the full press release, visit https://ibn.fm/JeFht

About Sustainable Green Team Ltd.

The Sustainable Green Team is a wholesale manufacturer and national supplier of wood-based mulch, lumber products and soil, including soil amendment products HumiSoil(R) and XLR8(R). The company sells directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores, food stores, and wholesale distributors. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that has been historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation. For more information about the company, visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora (NASDAQ: FLGC), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has announced its entry into a partnership with TruHC Pharma, a medical cannabis expert based in Hamburg, Germany. TruHC holds an EU-GDP certification as an importer, distributor and manufacturer of medical cannabis, and operates a production facility with a cutting-edge cannabis laboratory for which an EU-GMP license is expected by the end of September. Hendrik Knopp, a respected lawyer, accomplished entrepreneur and leader who has been pivotal in establishing Germany’s medical cannabis landscape, along with the TruHC team, join the Flora family. “I am delighted to welcome Hendrik Knopp and the TruHC team to the Flora group. Their expertise and achievements within the industry, particularly in pioneering medical cannabis in Germany, make them invaluable partners,” said Clifford Starke, chief executive officer of Flora. “We are poised to execute our strategic business plan and capture a meaningful market share in Germany.”

To view the full press release, visit https://ibn.fm/1u63q

About Flora Growth Corp.

Flora is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution. For more information on Flora, visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a company working to develop a global financial technology ecosystem comprising a network of mobile money platforms, technologies, applications, products, and services. “The technologies, the company’s website states, are meant to ‘make it easy to move money across borders to almost any place in the world, in virtually any currency, using your mobile phone or laptop.’ FEXD aims to use emerging technologies such as blockchain, web 3.0, artificial intelligence (“AI”), and the metaverse to reduce costs and accelerate the processing of money transfers, loans and other lifestyle services, which will benefit consumers and businesses in many countries, according to Dr. Sainful Khandaker, CEO, president and founder of FEXD,” a recent article reads. “With a goal of leveraging the power of such emerging technologies to benefit businesses and consumers downstream, FEXD is not only developing platforms and applications that support cashless transactions but also seeking to acquire and merge with high-growth global fintech companies primarily operating in South Asia with a high volume of customers and extensive network of agents.”

To view the full article, visit https://ibn.fm/XQZqy

About Fintech Ecosystem Development Corp.

Fintech Ecosystem Development is a special purpose acquisition company formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector. The company is sponsored by Revofast LLC and the management team led by CEO, president and founder Dr. Saiful Khandaker and a group of experienced fintech business and technology innovators. For more information about the company, please visit www.FintechEcosys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services’ (OTCQB: SHRG) wholly owned subsidiary, MyTravelVentures, recently completed its first-ever Venture Trip at the Sensira Resort and Spa in Cancun, Mexico. “According to a report from the U.S. Travel Association, total travel spending in May improved to 1.4% above May 2022 levels and was up 5.5% year-to-date through May 2023. In addition, air travel demand remained above May 2022. Furthermore, Forbes is reporting that, even with continuing inflation, layoffs and a potential recession, ‘2023 travel trends show no slowdown,’” a recent article reads. “This is the ideal climate for MyTravelVentures to prosper and grow. The company’s subscription-based membership plan, which is available for a recurring monthly fee with no contracts or commitments, offers members full access to exclusive deals across the travel industry. These deals represent savings of up to 65% on a variety of services, including flights, hotels, transportation and events; the plan even includes nontravel-related services such as retailer discounts, cash-back programs and telehealth services. Even more exciting are the company’s curated, all-inclusive group vacation packages. These exclusive Venture Trips offer premium resort getaways with immersive experiences.”

To view the full article, visit https://ibn.fm/fefoY

About Sharing Services Global Corporation

Sharing Services is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Additional information is contained in the company’s 10-Q and 10-K filings with the Securities and Exchange Commission. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced that Hector Lombard, a professional mixed martial artist, bodybuilder, UFC fighter, and former Olympic judoka, has signed on as a brand ambassador for Safety Shot, the company’s first-of-its-kind rapid alcohol detoxification drink. Lombard is a social media influencer that has amassed a following of 3 million across platforms including Instagram and X (formerly Twitter). As a Cuban-Australian, Lombard’s global audience of sports and fitness enthusiasts is a key target demographic for Safety Shot. “We’re excited to have Hector come on board as Safety Shot’s first brand ambassador,” said Jupiter Wellness CEO Brian John. “As we gear up for launch in the fourth quarter, we plan to engage with many other brand ambassadors who make wellness a priority and communicate their positive message to a wide and diverse audience.”

To view the full press release, visit https://ibn.fm/KFwvi

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products and licensing royalties. The company recently acquired Safety Shot, the world’s first blood alcohol detox drink. Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for email alerts at JupiterWellness.com/email-alerts and by following Jupiter Wellness on Twitter and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Aditxt (NASDAQ: ADTX), a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system, announced an important update regarding its innovation programs and strategic M&A initiatives. The shareholder update provides the company’s planned strategy for achieving commercial scale. “Aditxt takes a stakeholder-driven approach to developing and deploying some of the most promising health innovations such as Pearsanta’s immune monitoring platform and Adimune’s immune modulation therapeutic,” Amro Albanna, Aditxt CEO, chairman and co-founder states in the update. “Our goal is to get our current programs to reach key clinical or commercial stage and expand our portfolio of innovations to address additional markets such as oncology and neurology.”

The company also issued a correction and replacement of its Aug. 17 announcement of a 1-for-40 reverse stock split. According to the update, the “First paragraph, first sentence of release should read: Aditxt, Inc. (NASDAQ: ADTX) (‘Aditxt’ or the ‘Company’), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock…”

To view the full press releases, visit https://ibn.fm/51gvr and https://ibn.fm/fQzl0

About Aditxt Inc.

Aditxt is a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system. Headquartered in Richmond, Virginia, the company has operations in Silicon Valley, California, and New York, New York. Aditxt’s mission of “Making Promising Innovations Possible, Together” is defined by its growing ecosystem of research institutions, global industry partners and shareholders who inform and inspire its mission. Aditxt’s diverse innovation portfolio includes: Adimune(TM), developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir(TM), focused on identifying, developing, and commercializing new ways to treat infectious diseases; and Pearsanta(TM), which offers personalized immune monitoring for a wide range of health conditions, including hereditary cancer, wounds and cardiomyopathy. For more information, visit the company’s websites at www.Aditxt.com, www.Adimune.com and www.Pearsanta.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• FEXD is developing a global financial technology ecosystem that will address unmet mobile money needs in developing and industrialized markets and make it easier and more affordable to transact digitally
• The company aims to use emerging technologies such as AI to reduce costs associated with and fast-track the processing of money transfers and loans
• AI is a powerful technology that has been positively associated with the improvement in digital financial inclusion
• The technology is used in credit risk assessment, investment-related decision-making, fraud detection and prevention, prediction, and customer service
• With FEXD eying digital money transfers, which are unfortunately prone to cyber threats and fraud attempts, the company aims to tap into the power of AI to promote security and efficiency, thus driving digital financial inclusion

Long before large language models (“LLMs”) like ChatGPT and Bard democratized artificial intelligence (“AI”), this powerful technology existed and was deployed in different industries. The banking, financial services, and insurance (“BFSI”) industry, for instance, is recognized as one of the earliest and most prominent adopters of the technology, having first incorporated some form of AI about three and a half decades ago (https://ibn.fm/wZMQi). But the rise of new frontiers in AI, such as generative AI, of which LLMs are part, has created new opportunities that incumbents and startups can use to their benefit.

The earliest implementation of AI in the BFSI space was in the domain of credit risk assessment. And many years on, financial services companies such as banks and lenders still use the technology to assess the creditworthiness of customers. But, compared to the formative years, AI has evolved, thanks in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, has announced that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m. Eastern Time on Aug. 18, 2023. Commencing with the opening of trading on the Nasdaq Capital Market on Aug, 18, the company’s common stock will trade under the same symbol ADTX on a post-split basis. The reverse stock split was approved by the company’s stockholders at the annual meeting held on Aug. 16, 2023, with the final ratio determined by the company’s board of directors.

To view the full press release, visit https://ibn.fm/JJfQD

About Aditxt Inc.

Aditxt is a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system. Headquartered in Richmond, Virginia, the company has operations in Silicon Valley, California, and New York, New York. Aditxt’s mission “Making Promising Innovations Possible, Together” is defined by its growing ecosystem of research institutions, global industry partners and shareholders who inform and inspire its mission. Aditxt’s diverse innovation portfolio includes: Adimune(TM), aimed at developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir(TM), focused on identifying, developing, and commercializing new ways to treat infectious diseases; and Pearsanta(TM), which intends to offer personalized immune monitoring for a wide range of health conditions, including hereditary cancer, wounds and cardiomyopathy. For more information, visit the company’s websites at www.Aditxt.com, www.Adimune.com and www.Pearsanta.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a global vendor of Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, is capturing industry attention with its most recent financial report; the report included revenues of $2.7 million, which is a significant increase of 180% compared to the same period 2022. According to the report, much of the growth comes from sales of Siyata Mobiles flagship product, the SD7, which brought in $1.9 million in revenue during Q2 2023. The company noted that the sharp increase in sales is an indication of the increasing demand and popularity of the SD7 handset among customers. In addition to the increase in revenue, the report showed gross profits of $804,000, equivalent to 29.7% of revenues, a substantial improvement compared to the previous year’s $109,000, which accounted for 11.2% of revenues. The company noted that this increase was largely attributed to a strategic shift in selling more SD7 handsets. With these growing numbers as a backdrop, combined with the company’s cash on hand and experienced sales team, Siyata says its market cap is undervalued at approximately $7 million.

“Growth continued to accelerate in the second quarter with a 180% year-over-year increase in revenue on strengthening sales of our mission-critical PoC (MCPTT) SD7 solution,” said Siyata Mobile founder and CEO Marc Seelenfreund in the press release. “Adoption of our critical communications devices is expanding. We have received purchase orders for the SD7 handset and its accessories of more than $5 million since the start of 2023, and our resellers also anticipate an increase in demand. Just as important, the increase in orders reaches beyond emergency services to include education, healthcare, industrial, and enterprise use cases among others. Given our performance in the first half of the year and our expanding sales pipeline, we are increasingly optimistic that 2023 will be a strong growth sales year for Siyata.”

To view the full press release, visit https://ibn.fm/6B7dQ

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation, Push-to-Talk over cellular devices, cellular booster systems and video monitoring systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software that we license with off-the-shelf hardware providing our customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SRM Entertainment (NASDAQ: SRM), a company that designs, develops and manufactures custom toys and souvenirs for the world’s largest theme parks and entertainment venues, has closed on its initial public offering. The offering was comprised of 1,250,000 shares of its common stock that were offered to the public at an initial price of $5 per share. According to the announcement, SRM shares began trading on the NASDAQ Capital Market on Aug. 15, 2023. The offering resulting in gross proceeds of $6.25 million, before standard underwriting discounts and commissions and other related expenses are deducted. The announcement also noted that the company has granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of common stock at the same public offering price, minus underwriting discounts and commissions.

To view the full press release, visit https://ibn.fm/BBTNo

About SRM Entertainment Inc.

SRM Entertainment designs, develops and manufactures custom toys and souvenirs for the world’s largest theme parks and entertainment venues. The company provides exclusive custom products that are available worldwide at venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld and other attractions. The company also recently launched its retail product line, which includes patented SMURFS Sip with Me cups. For additional information about this company, please visit www.SRMEntertainment.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO) today announced that its CEO and President Richard T. Schumacher and Director of Marketing and Sales John B. Hollister are the featured speakers at an online webinar scheduled for 11 a.m. ET on Thursday, Aug. 17, 2023. The webinar will showcase an overview of Pressure BioSciences and its core technologies and products, as well as outline the transformative impact of the company’s powerful UltraShear platform and its multiple applications in health and wellness. “The combination of our UltraShear launch progress, the powerful enhancement that UltraShear offers in multiple billion-dollar industries, the impending publication of UltraShear bioavailability study results, and efforts focused on the improvement of our balance sheet and future revenue, provide a powerful forward-focused opportunity for our investors,” Schumacher said. “We continue to work with multi-billion-dollar international conglomerates, well-funded startups, and many companies in between, as we facilitate the adoption of UltraShear. We believe our IP estate is worth many times our current enterprise value. During my professional career, I have priorly founded/co-founded three successful public companies, yet in my opinion, none had close to the potential that we have in PBIO. For these and other reasons, we believe PBIO’s future is both exciting and bright.”

To view the full press release, visit https://ibn.fm/kUBHt

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its products utilize both constant and alternating pressure. The company’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, is taking steps to begin production of its newly acquired Safety Shot product, the world’s first blood alcohol detox drink. The company has engaged an experienced contract beverage manufacturer/packer with facilities across the United States for production; the company anticipates the drink will be available in a 12-ounce sleek can. In addition, company officials noted that Jupiter Wellness has created a multichannel strategy designed to dominate e-commerce, win retail shelf space and establish longstanding ties with key distribution and sales partners. Members of the media are invited at attend the unveiling of the new product, slated for Sept. 15, 2023, at 4 p.m. at company headquarters in Jupiter, Florida. The company noted that its newest offering pushes the boundaries of innovation by creating an exciting new product category in the growing hangover remedies market: rapid alcohol detoxification. Its Safety Shot offering is designed to reduce intoxication levels by one-half within 30 minutes using a patented formula that accelerates the process of converting alcohol into sugar in the body. “I have given Safety Shot to dozens of people now and trying the drink is believing in the drink,” said Jupiter Wellness CEO Brian John in the press release. “We look forward to allowing members of the media to come see Safety Shots’s incredible results for themselves.”

To view the full press release, visit https://ibn.fm/fsByD

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products as well as licensing royalties. The Company recently acquired Safety Shot, the world’s first blood alcohol detox drink. For additional information about this company, visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today announced SFDA (Saudi Food and Drug Authority) approval of sugarBEAT(R), its non-invasive wearable glucose sensor. According to the update, the news comes after a year of liaisons with the SFDA through TPMENA, the company’s licensee in the Middle East. This is seen as a major breakthrough in product commercialization in the largest territory in the Middle East, and a region with one of the world’s highest diabetes prevalence rates. Based on a report in 2021 by the Economist Intelligence Unit, nearly 4.5 million people, or 18.3% of the adult population in Saudi Arabia, have diabetes. This compares to a global average of 9.3%. Further, it is estimated that 39% of adults with diabetes in Saudi Arabia are unaware that they have the condition, leaving them at higher risk of complications without management. This segment of nearly 9 million is ideally placed to benefit from sugarBEAT(R) sensors within a general metabolic health improvement program. Such a program specifically addresses obesity to avoid diabetes and other complications and has shown efficacy within trials with the U.K.’s National Health Service.

To view the full press release, visit https://ibn.fm/wA9uu

About Nemaura Medical Inc.

Nemaura is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark approved Class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital health care subscription service as a general wellness product as part of its BEAT(R) diabetes program that is currently undergoing pilot studies. Additionally, Nemaura has launched a beta trial of Miboko, a metabolic health and well-being program using a non-invasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. The company sits at the intersection of the global type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023. For more information, visit www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, has begun preparations for good manufacturing practices (“GMP”) production of a capsule formulation of CYB003, its proprietary deuterated psilocybin analog in development for the potential treatment of Major Depressive Disorder (“MDD”). According to the announcement, the formation is stable, dose and patient friendly, and is commercially scalable. The company noted that it anticipates shipping the CYB003 capsules to clinical sites by first quarter 2024. “The development of a capsule formulation of CYB003 represents a meaningful advancement toward a commercially viable and more convenient dosing option that is potentially suitable for a future phase 3 trial,” said Cybin CEO Doug Drysdale in the press release. “We are very pleased with the progression of our CYB003 program in MDD thus far. Preparations for GMP manufacturing of CYB003 capsules continue to build on our efforts to progress an improved treatment option for people with major depressive disorder. Coupled with our partnership with Worldwide Clinical Trials, a global CRO with deep expertise in psychedelic clinical trials, and the development of EMBARK(CT), a scalable model of our psychedelic facilitation program, these efforts are a testament to our clinical execution and capabilities at each step along our development pathway.”

To view the full press release, visit https://ibn.fm/rFsom

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer. The company today provided an interim analysis from its ongoing phase 1B trial of Next Generation Capecitabine (“NGC-Cap”) in patients with gastrointestinal cancer, which identifies a personalized treatment approach that may yield improved safety and treatment efficacy. “The presence of DPD as expressed by the plasma concentration of FBAL provides us important information that may confirm our hypothesis that we can optimize our dosing of NGC-Cap to maintain efficacy and minimize side effects by carefully tracking each individual patient following an initial dosing of our novel chemotherapy,” said Sian Bigora, Pharm.D., Processa’s chief development and regulatory officer. “By following the chemical concentration in the plasma in each patient, we may be able to actually optimize therapy through individualization of each patient’s dosing regimen. We find these results, albeit early results, to be very encouraging.”

To view the full press release, visit https://ibn.fm/LFk1N

About Processa Pharmaceuticals Inc.

Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also increase the probability of FDA approval for its Next Generation Chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. Its approach to drug development is based on more than 30 years of drug development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, Processa has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s Next Generation Chemotherapy drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each Next Generation Chemotherapy drug. Currently in its pipeline are three Next Generation Chemotherapy drugs: Next Generation Capecitabine (“PCS6422” and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (“PCS3117” to treat pancreatic, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

GolfLync, the premier social media platform for golf enthusiasts, is proud to announce a significant milestone, surpassing 50,000 members across the United States. The exponential growth is a testament to the platform’s ability to bring golfers together, fostering vibrant golfing communities and connections that continue to flourish.

From local golf clubs to nationwide networks, GolfLync’s Virtual Golf Clubs(TM) (“VGC”) have transformed the way golfers connect, share, and experience the game they love. Members are embracing the platform’s innovative features, with private and public VGCs serving as hubs for planning…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

EverGen (TSX.V: EVGN) (OTCQX: EVGIF) today announced plans to release its 2023 second quarter financial results after market close on Aug. 23, 2023. At 10:00 a.m. ET on the following day, Aug. 24, EverGen will hold a results and corporate update conference call, hosted by Chief Executive Officer Chase Edgelow. Interested parties should visit https://ibn.fm/6TXZK to register for the event and access the webcast.

To view the full press release, visit https://ibn.fm/pcIwO

About EverGen Infrastructure Corp.

EverGen, Canada’s renewable natural gas (“RNG”) infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. Headquartered on the West Coast of Canada, EverGen is an established independent renewable energy producer, which acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste to energy and related infrastructure projects. EverGen is focused on Canada, with continued growth expected across other regions in North America and beyond. For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Blue Hat Interactive (NASDAQ: BHAT) has completed the issue of $29.8 million of ordinary shares. According to the announcement, the company anticipates continued development of the commodities trading business, especially in trading gold and jewelry, which will create sustainable values for global shareholders. “The completion of this issuance marks a significant development for BHAT, continuing the company’s transformation to commodity trading since the third quarter of 2022,” said BHAT CEO Xiaodong Chen in the press release. “The company has appointed Mr. Pan Weicheng as the CSO in May 2023. Under the leadership of Mr. Pan, a new business system was established — commodity trading with artificial intelligence analysis. At the same time, BHAT has also divested its Variable Interest Entity (‘VIE’) structure within mainland China. These adjustments are strategic and enduring. BHAT will gradually shift towards international growth. In the future, BHAT plans to expand and shift its business’s focus to Southeast Asia and the United States. The presence and development of artificial intelligence is inevitable. Thus, utilizing AI technology to influence the existing commodity trading framework is at the core of our new strategy. We are enthusiastic about this forward-thinking endeavor. We envision a working model that is fully implemented and results in positive outcomes, which we have already begun to achieve in the past three quarters.”

To view the full press release, visit https://ibn.fm/n6MkF

About Blue Hat Interactive Entertainment Technology

Blue Hat is developing a commodity trading with artificial intelligence analysis focus.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Financial analysts, business owners, investors, financial institutions, and regulators, are invited to attend FinovateFall, held in the Marriott Marquis Times Square, New York City, September 11-13, 2023. The much-awaited event is returning to bustling New York City. Featuring interactive sessions, live demos, and unlimited entertainment options, FinovateFall promises to be a fintech extravaganza that sparks innovation and creativity.

Important thought leaders will share their perspectives on the future of finance through engaging seminars and live demos showing the latest in fintech developments, all while offering off-hours NYC entertainment opportunities that will keep participants captivated. New York’s unmatched…

Read More>>

To learn more, please visit https://ibn.fm/sLe8Y.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from certain dentofacial abnormalities, is reporting its financial and operating results for the second quarter and six-month period ended June 30, 2023. Highlights of the report include a 31% decrease in operating expenses quarter over quarter and 25% year to date, a reflection of the company’s cost-cutting initiatives; revenue of $3.4 million for the Q2 2023 and $7.3 million for the six-month period, compared to $4.2 million and $7.8 million for the three and six months ended June 30, 2022, respectively; and gross profit of $2.1 million for the quarter and $4.4 million for the six-month period, compared to $2.6 million and $5.1 million for the comparable periods in 2022, respectively. The company reported cash and cash equivalents totaled $3.9 million on June 30, 2023. Operational highlights include an estimated 40,000 patients being treated with the Vivos Method and more than 1,800 dentists trained in the use of the Vivos Method and related value-added services as well as the announcement of the results of a clinical observational study on the application of the POD(R) (now being rebranded as the Vida) in the treatment and prevention of migraine headaches.

“Throughout this year, we significantly reduced our cash burn, which led to a 31% second quarter over quarter, and 25% year over year reduction in operating expenses,” said Vivos chair and CEO Kirk Huntsman in the press release. “At the same time, we expanded our product offerings to address a broader spectrum of patient needs and price points to drive revenue growth. This included our acquisition of certain key patents, trademarks, product rights and trade secrets earlier in 2023, which filled a gap in our product offerings to providers and patients. We continue to believe that these developments will allow us to begin to see revenue improvement here in the second half of 2023. . . . Through the combination of our strategic revenue initiatives, internal operating cost reductions and new capital raising initiatives, we believe we have positioned Vivos to achieve revenue growth and, ultimately, cash-flow positive operations and profitability in the foreseeable future. In summary, while the larger economic and market environment is creating challenges for both the medical and dental communities, Vivos has taken steps to address those challenges, and our long-term growth drivers remain in place.

To view the full press release, visit https://ibn.fm/7DdAx

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in the treatment of more than 40,000 patients worldwide by more than 1,800 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

VPR Brands (OTC: VPRB), a licensing company owning patents and trademarks as well as a market leader for the design and sale of electronic cigarettes, or vaporizers, for nicotine, cannabis and cannabidiol (“CBD”) and other related accessories such as lighters, is reporting its second-quarter 2023 financial results. Highlights of the report show increased revenues and record profits when compared to previous quarters. The company noted that while it was able to increase Q2 2023 revenues over 2022 by an estimated $1 million to $1,909,529, and year-to-date six-month revenue by more than $2 million to $4,990,550, it was able to reduce operating expenses for the two time periods as well. The report showed that net income for VPR Brands increased to more than $928,322 in Q2 2023, up from $73,733 in Q2 2022 and $953,636 year to date, compared to a net loss of $73,508 for the six-month period ending June 30, 2022. “We have been able to successfully license and monetize our ELF brand trademark this year while aggressively protecting the mark in the courts and creating a monumental asset for the company and we are now focusing on developing business for our other trademarks as well,” said VPR Brands CEO Kevin Frija in the press release. “We believe partnering as a Licensor with experienced and well capitalized licensees to expand our brand portfolios business is the model that will work best for the company in the long run.”

To view the full press release, visit https://ibn.fm/wSX25

About VPR Brands LP

VPR Brands is a technology company, as well as an IP holding company. The company is engaged in various monetization strategies of a U.S. patent that the company owns covering electronic cigarette, electronic cigar and personal vaporizer patents, as well as a patent for an inverted pocket lighter. The company also has several trademarks (ELF, PHANTOM, HRB, VPOD, VAPOR X, and RIPPER) for which it is also engaged in licensing and various monetization strategies. VPR Brands also designs, develops, markets and distributes products, including the HoneyStick brand of vaporizers and the Goldline CBD products, oriented toward the cannabis markets. This allows the company to capitalize on the rapidly growing expansion within the cannabis markets. The company is also identifying electronic cigarette companies that may be infringing its patents and trademarks and exploring options to license and/or enforce those patents. The company is now also selling DISSIM brand pocket lighters for which it holds a U.S. patent and patents pending. The company also has patents pending in the cigar accessory space and sells these proprietary accessories. For more information about the company, visit www.VPRBrands.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork